HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 245711Generated: November 2, 2026
Potassium Carbonate → HCID 178432914, compound
https://huagongshe.com/reaction/245711
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | 2-Bromo-1,1-difluoroethane | HCID 136186 | — |
| Reactant | HCID 178432913 | HCID 178432913 | — |
| Reactant | HCID 178523781 | HCID 178523781 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178432914 | HCID 178432914 | — |
Reaction Steps
Using the procedures described in example 17 (trans)-4-(benzyloxycarbonylamino)cyclohexanecarboxylic acid was used to prepare (trans)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexanamine. The latter compound (0.217 mmol, 67.1 mg) was dissolved in N,N-dimethylformamide, potassium carbonate (0.651 mmol, 90 mg) was added followed by 2-bromo-1,1-difluoroethane (0.217 mmol, 17.47 μl, 31.5 mg) and the reaction mixture was stirred in the micro wave at 60° C. After one hour another amount of 2-bromo-1,1-difluoroethane (0.217 mmol, 17.47 μl, 31.5 mg) was added and the reaction mixture was stirred in the micro wave at 60° C. for another hour. The reaction mixture was filtered, the filter was rinsed with acetonitrile and the filtrate was concentrated. The residue was purified by column chromatography (silica gel, gradient dichloromethane/methanol 10/0 to 9/1) to give (trans)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)-N-(2,2-difluoroethyl)cyclohexanamine (39.8 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08658794B2 |
|---|
| Source dataset | uspto-grants-2014_02 |
|---|
| ORD ID | ord-164193d9d89c492e98c0d33be28e97c2 |
|---|
| Source note | uspto-grants-2014_02 |
|---|